Gastroesophageal Reflux Disease in Children with Cystic Fibrosis

Marcin A Dziekiewicz1, Aleksandra Banaszkiewicz2, Agnieszka Urzykowska3

  • 1Department of Pediatric Gastroenterology and Nutrition, Medical University of Warsaw, 1 Dzialdowska St., 01-184, Warsaw, Poland. marcin.dziekiewicz@wum.edu.pl.

Insights

Gastroesophageal reflux (GER) is highly prevalent in children with cystic fibrosis, often without typical symptoms. pH-impedance monitoring is recommended for accurate diagnosis in this population.

Area of Science:

  • Pediatric Gastroenterology
  • Pulmonology
  • Gastroesophageal Reflux Disease

Background:

  • Gastroesophageal reflux (GER) is frequently observed in pediatric cystic fibrosis (CF) patients.
  • Understanding the incidence and characteristics of GER in CF is crucial for patient management.

Purpose of the Study:

  • To determine the incidence of GER in children with cystic fibrosis.
  • To characterize the nature and location of reflux episodes in this cohort.

Main Methods:

  • A multicenter, prospective study involving 44 pediatric patients with cystic fibrosis (age >1.5 years).
  • All participants underwent 24-hour pH-impedance monitoring.
  • Reflux episodes were classified based on acidity and location (proximal esophagus).

Main Results:

  • GER was diagnosed in 54.5% of the children.
  • A total of 1585 reflux episodes were detected, with 75.6% being acidic.
  • Over 43% of reflux episodes reached the proximal esophagus, and typical GER symptoms were absent in most patients.

Conclusions:

  • The incidence of GER in children with cystic fibrosis is very high, frequently asymptomatic.
  • Standard pH-metry may be insufficient due to a high number of proximal reflux episodes.
  • pH-impedance monitoring is advocated for diagnosing GER in pediatric CF patients, given the risk of aspiration associated with proximal reflux.

Related Concept Videos

Gastroesophageal Reflux Disease II: Clinical Features and Management01:29

Gastroesophageal Reflux Disease II: Clinical Features and Management

Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
1.1K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
626
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
2.2K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
1.2K
Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
1.5K